Guideline de Dislipidemia da ESC e Hipertensão Arterial da AHA - Fofoca Científica #6

Another episode of Scientific Gossip is out, this time live from the celebrated ESC congress. We bring you two fresh guidelines packed with very important news for clinical practice: ESC Dyslipidemia and AHA Hypertension. Want to learn more about this topic? See our thread on the DLP guideline from the ESC congress: https://www.tadeclinicagem.com.br/gui... TdC LDL Target Podcast: https://www.tadeclinicagem.com.br/con... ESC Dyslipidemia Guideline: https://www.escardio.org/Guidelines/C... AHA Hypertension Guideline: https://www.ahajournals.org/doi/10.11... 🚨 www.tadeclinicagem.com.br/guia - Get the TdC Guide with a 7-day free trial 🚨 🔴 Join over 5,000 subscribers. Subscribe to the Guide, save time, and stay up-to-date effortlessly. Like and follow TdC on other social media: 🩺 Instagram: @Tadeclinicagem 🩺 TikTok: https://www.tiktok.com/amp/tag/tadecl... Learn about Clinical Medicine in an educational, fun, and evidence-based way! Share TdC with your friends! ⚠️ ATTENTION: This content is intended exclusively for medical education purposes and does not replace the individualized evaluation of a healthcare professional. The information presented here should not be interpreted as medical advice, prescription, or treatment recommendation. If you have any questions about your health or treatments, always consult a doctor or qualified professional.

Dislipidemia ESC  2025: novas metas, novos fármacos, nova prática (DozeCast 195)
▶︎

Dislipidemia ESC 2025: novas metas, novos fármacos, nova prática (DozeCast 195)

ESC 2025: Potassium and Arrhythmias, Apixaban in VTE, B-blockers After AMI - Scientific Gossip #7
▶︎

ESC 2025: Potassium and Arrhythmias, Apixaban in VTE, B-blockers After AMI - Scientific Gossip #7

Nova diretriz de dislipidemias: o que você precisa saber?
▶︎

Nova diretriz de dislipidemias: o que você precisa saber?

DIAGNOSTIQUEI HIPERTENSÃO, E AGORA? Avaliação e seguimento da hipertensão arterial sistêmica
▶︎

DIAGNOSTIQUEI HIPERTENSÃO, E AGORA? Avaliação e seguimento da hipertensão arterial sistêmica

Tirzepatida vs Semaglutida, Finerinona na ICFEp e Metotrexato para sarcoidose - Fofoca Científica #1
▶︎

Tirzepatida vs Semaglutida, Finerinona na ICFEp e Metotrexato para sarcoidose - Fofoca Científica #1

Statins Exposed: Why the Evidence Doesn't Match the Hype
▶︎

Statins Exposed: Why the Evidence Doesn't Match the Hype

Episode 327 - ESC 2025 Update on the Dyslipidemia Guideline
▶︎

Episode 327 - ESC 2025 Update on the Dyslipidemia Guideline

Friday Mace Club 🫀HIGHLIGHTS ESC 2025 BETAMIDANBLOCK, REBOOT-CNIC, DIGIT-HF, NEOMINDSET, BAXhtn
▶︎

Friday Mace Club 🫀HIGHLIGHTS ESC 2025 BETAMIDANBLOCK, REBOOT-CNIC, DIGIT-HF, NEOMINDSET, BAXhtn

Novo Guideline de Dislipidemia do AACE
▶︎

Novo Guideline de Dislipidemia do AACE

ENFERMAGEM EM SAÚDE DA CIRANÇA E DO ADOLESCENTE - UNIDADE 06
▶︎

ENFERMAGEM EM SAÚDE DA CIRANÇA E DO ADOLESCENTE - UNIDADE 06

Neuroscientist explains: the BEST techniques for FOCUS and CONCENTRATION
▶︎

Neuroscientist explains: the BEST techniques for FOCUS and CONCENTRATION

The Fasting Doctor Reveals: These FASTING SECRETS Melt Body Fat | Dr. Jason Fung
▶︎

The Fasting Doctor Reveals: These FASTING SECRETS Melt Body Fat | Dr. Jason Fung

💥ЗЕЛЕНСЬКОГО ПЕРЕГРАЛИ! Восени трагічний ФІНАЛ ВІЙНИ. Крах України БЛИЗЬКО? / ЦИБУЛЬКО, ЧОРНОВІЛ
▶︎

💥ЗЕЛЕНСЬКОГО ПЕРЕГРАЛИ! Восени трагічний ФІНАЛ ВІЙНИ. Крах України БЛИЗЬКО? / ЦИБУЛЬКО, ЧОРНОВІЛ

184 - Principais pontos das novas diretrizes brasileiras de cardiologia 2025 | Pocket Pill
▶︎

184 - Principais pontos das novas diretrizes brasileiras de cardiologia 2025 | Pocket Pill

DISLIPIDEMIA 1 | Aspectos Gerais
▶︎

DISLIPIDEMIA 1 | Aspectos Gerais

Dyslipidemia and Atherosclerosis Prevention - SBC 2025 Update
▶︎

Dyslipidemia and Atherosclerosis Prevention - SBC 2025 Update

Diretriz de obesidade e risco cardiovascular
▶︎

Diretriz de obesidade e risco cardiovascular

Episode 339 - Surviving Sepsis: Sepsis Controversies - The Return
▶︎

Episode 339 - Surviving Sepsis: Sepsis Controversies - The Return

74 - Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia
▶︎

74 - Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia

Dr. Andy Galpin: Optimal Nutrition & Supplementation for Fitness | Huberman Lab Guest Series
▶︎

Dr. Andy Galpin: Optimal Nutrition & Supplementation for Fitness | Huberman Lab Guest Series